Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
October 31, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
October 30, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
October 29, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
October 08, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will...
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
September 17, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for comprehensively...
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 14, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced the company...
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
July 30, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
July 09, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will...
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 23, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology Reports First Quarter 2024 Financial Results
April 30, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...